The changing face of fungal infections in health care settings.
about
Epidemiology of invasive candidiasis: a persistent public health problemIdentification of Aspergillus fumigatus Surface Components That Mediate Interaction of Conidia and Hyphae With Human Platelets.Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses.Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.Invasive candidiasis in non-hematological patients.Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.Recent Advances in the Use of Drosophila melanogaster as a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi.Clinical significance of the isolation of Candida species from hospitalized patients.Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testGeographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.Combination antifungal therapy: the new frontier.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingDifferential Gene Expression of Heat Shock Protein 90 (Hsp90) of Candida albicans obtained from Malaysian and Iranian Patients.Tuberculosis and pulmonary candidiasis co-infection present in a previously healthy patientEvaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.Treatment of invasive candidiasis in the elderly: a reviewCandidemia in the 21st century.Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics.Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.Caspofungin: when and how? The microbiologist's view.A case of pediatric acute lymphoblastic leukemia with invasive candidiasis: short review.Healthcare-associated outbreaks due to Mucorales and other uncommon fungi.In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.The epidemiology of fungemia in an infectious diseases hospital in Mexico city: A 10-year retrospective review.New insight into amphotericin B resistance in Aspergillus terreus.TUBERCULOSIS INFECTION MIGHT INCREASE THE RISK OF INVASIVE CANDIDIASIS IN AN IMMUNOCOMPETENT PATIENT.Fusaric acid contributes to virulence of Fusarium oxysporum on plant and mammalian hosts.Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.Admission to the Intensive Care Unit is Associated With Changes in the Oral Mycobiome.In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates.Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.Intraleukocytic Candida is Diagnostic of Pathological Candidemia.Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.What are fungal infections?Invasive fungal infections secondary to acute-on-chronic liver failure: a retrospective study.Antifungal effect of lavender honey against Candida albicans , Candida krusei and Cryptococcus neoformans.A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients.Disseminated phaeohyphomycosis in weedy seadragons (Phyllopteryx taeniolatus) and leafy seadragons (Phycodurus eques) caused by species of Exophiala, including a novel species.The velvet complex governs mycotoxin production and virulence of Fusarium oxysporum on plant and mammalian hosts.
P2860
Q29616758-A70C10A3-1B29-44DD-B189-E3F56262DBD2Q33421462-3C3C3DB6-84AB-4322-A2FD-ED82F76AE5FDQ33704835-FDE22765-7844-401B-B863-49956C24D090Q33707593-C8712130-3ACF-44FF-A003-ADB0186F293DQ34006585-D2ECAB9A-5D45-414E-8C96-8E46AF2C43CCQ35010671-AC07FF3E-A6A8-4BD9-ACA9-A3A736EF174DQ35066649-7A3268CD-D061-4262-A36D-A9F12DB6685BQ35821280-8C9BA807-84BD-4B83-AD76-121021682A63Q35881281-AA9AC3ED-D5A9-45B7-9E9B-1A883A28F137Q35913918-0DAD6644-DE87-4017-801E-D877B2E1E6DAQ36497888-A819A48A-BCF3-44EC-88F7-1355308EAEFEQ36895652-07C76CA3-9F42-4A43-84D3-9D2F506F4099Q37051529-589A90F1-690D-45BF-99D5-08CF86EAD36EQ37069735-DC288900-1691-4F3C-B28C-8A9BDA029F00Q37154923-827068A6-A97A-46D9-AAF9-59DA13288F7BQ37158073-284012CB-C25F-4781-AB08-41EDC0B2BD54Q37170218-0557B174-9D86-4E5E-B693-C7E83C3851A0Q37225681-B1E8CEA3-75FB-45FC-B832-44116D47489BQ37417354-1B8355B5-D920-47C3-8F8A-3E08E105CAF2Q37785979-5E05FCBA-4119-45D9-A879-49395E338727Q37888750-CCA647AA-49C6-4520-BA07-8E024BB595FEQ38261651-8DF0143E-1F70-4284-972A-2F0FA080B707Q38491799-ADDC34A9-95AF-4444-BB0F-C8CAE6DF4240Q38725931-315233AC-02E6-451C-8A5F-8D849107136AQ38818774-F5F85BAB-4975-45CF-AABD-8E2143779CAFQ39767448-70017021-BD55-4F63-9021-5616748B03ACQ40146203-EA39570A-B27F-4B0C-AD27-5EE1D7ED0D21Q40369620-0DFD1C60-F650-4543-882D-4383F3F45178Q40757551-8A3837CD-CA12-452D-ABC3-51B3CAD8C7A8Q40785545-48EC7F0D-C4C2-42C3-A514-6D2AF09CB8F5Q41018464-FE6FBEEB-E76B-4158-AAEE-7E21774D60CAQ41543735-20E3D106-078A-49D9-9137-D3996B0180A9Q41901751-D77DA150-0196-4627-A22B-58D0FA50137CQ42107963-FF8FB435-2CDE-4A6A-B010-1B4597A29268Q42148730-BFB700C0-C9E0-46FE-9245-059F23B311B6Q42276897-30D77BE5-D678-4A9F-9E3A-8F88A2652F95Q42908169-240AE6C8-1095-49CE-A42B-C07E31AF375EQ43017233-01CDE897-F3DB-4ADF-A244-85210293F0C6Q44198192-062B1CD1-8F90-4A5C-8B00-2BE30BE288F4Q44851507-DF00B0BA-8B2A-48C1-8243-397A919A7FFB
P2860
The changing face of fungal infections in health care settings.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The changing face of fungal infections in health care settings.
@ast
The changing face of fungal infections in health care settings.
@en
type
label
The changing face of fungal infections in health care settings.
@ast
The changing face of fungal infections in health care settings.
@en
prefLabel
The changing face of fungal infections in health care settings.
@ast
The changing face of fungal infections in health care settings.
@en
P2860
P356
P1476
The changing face of fungal infections in health care settings.
@en
P2093
Scott K Fridkin
P2860
P304
P356
10.1086/497138
P407
P577
2005-10-13T00:00:00Z